Table 1. Characteristics of patients with atrial fibrillation (prevalent oral anticoagulant [OAC] users and patients who started an OAC by the GP).
| Patient characteristics | n = 12 516 |
|---|---|
| Age (years, mean, sd) | 77.2±8.0 |
| Sex (% female) | 45.4 |
| Type of OAC (% DOAC) | 43.1 |
| Type of user (% starter) | 3.8 |
| Comorbidity | |
| Thrombosis (%) | 1.5 |
| Embolism (%) | 0.8 |
| CVA or TIA (%) | 14.3 |
| Heart failure (%) | 18.3 |
| Depression (%) | 3.4 |
| Renal function | |
| eGFR ≥50 (%) | 66.6 |
| eGFR <50 en≥30 (%) | 14.2 |
| eGFR <30 (%) | 2.6 |
| eGFR n.a. (%) | 16.6 |
| Comedication | |
| Antidiabetic drugs (%) | 20.7 |
| Cardiovascular drugs (%) | 95.5 |
| Antidepressants (%) | 13.3 |
| Benzodiazepines (%) | 17.0 |
| Gastrointestinal drugs (%) | 65.1 |
| No comedication (%) | 1.8 |
CVA = cerebrovascular accident. DOAC = direct oral anticoagulant. eGFR = estimated glomerular filtration rate. OAC = oral anticoagulant. TIA = transient ischaemic attack.